It is well-known that no local model-in theory-can simulate the outcome statistics of a Bell-type experiment as long as the detection efficiency is higher than a threshold value. For the Clauser-Horne-Shimony-Holt (CHSH) Bell inequality this theoretical threshold value is [Formula see text]. Abemaciclib On the other hand, Phys. Rev. Lett. 107,…[Read more]

Vor Biopharma secured $110 million in July to move its CD33-inactivated cell therapy into clinical testing. The company’s hope is that patients with high-risk acute myeloid leukemia who receive transplants of the gene-edited stem cells will then better tolerate therapies designed to destroy cells expressing CD33, an antigen found in abundance on…[Read more]